AUDEN MCKENZIE (PHARMA DIVISION) LIMITED
ActiveKey figures
† AUDEN MCKENZIE (PHARMA DIVISION) LIMITED filed these accounts on paper, so Companies House publishes them only as a scanned image. The figures for the years marked † were read automatically from the scan and kept only where the statements add up (for example net assets equal total equity), but a reading error is still possible — check the original accounts at Companies House.
Ratios
2025Sector comparison
SIC 21100Where the company stands among the 1,055 active companies whose first SIC code is 21100 (Manufacture of basic pharmaceutical products).
- GE HEALTHCARE LIMITED£5.6bn
- THERMO FISHER SCIENTIFIC LIFE HOLDINGS LIMITED£1.4bn
- LRC PRODUCTS LIMITED£1bn
- SMITHKLINE BEECHAM LIMITED£940m
- DECHRA LIMITED£780.1m
- IPSEN BIOPHARM LIMITED£588.2m
- ORTHO-CLINICAL DIAGNOSTICS£295.7m
- BESPAK EUROPE LIMITED£256m
- SEQIRUS VACCINES LIMITED£254.2m
- IOVANCE BIOTHERAPEUTICS UK LTD£199.7m
Positions are approximate. Figures come from each company's latest accounts; money and employee figures are compared only with companies that filed accounts in pounds for a period ending in the last two and a half years and are not dormant, so those groups are smaller than 1,055. The line on each bar marks the median.
Summary: AUDEN MCKENZIE (PHARMA DIVISION) LIMITED
What kind of company is it?
AUDEN MCKENZIE (PHARMA DIVISION) LIMITED is a private limited company registered with Companies House under company number 03835531. It was incorporated on 2 Sep 1999. Its status is active. The registered office is in Castleford (WF10). Its nature of business (SIC 2007) is manufacture of basic pharmaceutical products (21100), other professional, scientific and technical activities n.e.c. (74909).
How is the company doing financially?
The latest accounts in the database are for 2025 (period ending 31 Dec 2025); the company files full accounts. Turnover was £3,409,000. Profit for the year was £14,613,000. Net assets were £34,187,000, down 51.7% on the previous year. Total assets were £39,865,000 and total liabilities £5,678,000. Figures are available for 2 financial years (2024–2025).
How does it compare with similar companies?
Compared with 1,055 active companies whose first SIC code is 21100: By turnover it ranks lower than 83% of the 97 that publish turnover (median £23,360,137). By net assets it ranks higher than 92% of them (median £41,497). By total assets it ranks higher than 90% of them (median £308,978). It is older than 82% of them (median age 9.0 years).
Who runs and controls the company?
One person with significant control is registered.
When are its next filings due?
The next accounts are due by 30 Sep 2027. The next confirmation statement is due by 24 Aug 2027.
Filed accounts2024–2025
| 2024 † | 2025 † | |
|---|---|---|
| Turnover | 2,676,000 | 3,409,000 |
| Profit for the year | 2,797,000 | 14,613,000 |
| Total assets | 73,155,000 | 39,865,000 |
| Total liabilities | 2,356,000 | 5,678,000 |
| Net assets / total equity | 70,799,000 | 34,187,000 |
A dash (—) means no accounts were filed for that year or the item is not in the accounts; 0 is a zero stated in the accounts. Small companies usually file only a balance sheet, so the profit and loss account is often missing.
History
6 events- Actavis Uk Group Limited registered as a person with significant control
- Auden Mckenzie Holdings Limited ceased to be a person with significant control
- Financial year 2025 endedAccounts: turnover £3.4m, net assets £34.2m
- Financial year 2024 endedAccounts: turnover £2.7m, net assets £70.8m
- Auden Mckenzie Holdings Limited registered as a person with significant control
- Company incorporatedPrivate limited company
Dates as recorded at Companies House: incorporation, name changes, officer appointments and resignations, current and former persons with significant control, and the end of each financial year with figures in the database.